BE679347A - - Google Patents

Info

Publication number
BE679347A
BE679347A BE679347DA BE679347A BE 679347 A BE679347 A BE 679347A BE 679347D A BE679347D A BE 679347DA BE 679347 A BE679347 A BE 679347A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE679347A publication Critical patent/BE679347A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE679347D 1965-05-03 1966-04-12 BE679347A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR15527A FR4625M (cg-RX-API-DMAC10.html) 1965-05-03 1965-05-03

Publications (1)

Publication Number Publication Date
BE679347A true BE679347A (cg-RX-API-DMAC10.html) 1966-09-16

Family

ID=8577832

Family Applications (1)

Application Number Title Priority Date Filing Date
BE679347D BE679347A (cg-RX-API-DMAC10.html) 1965-05-03 1966-04-12

Country Status (3)

Country Link
BE (1) BE679347A (cg-RX-API-DMAC10.html)
FR (1) FR4625M (cg-RX-API-DMAC10.html)
GB (1) GB1090010A (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374835A (en) * 1980-01-31 1983-02-22 Laroche-Navarron, S.A. Piperazine derivatives of theophylline

Also Published As

Publication number Publication date
GB1090010A (en) 1967-11-08
FR4625M (cg-RX-API-DMAC10.html) 1966-11-28

Similar Documents

Publication Publication Date Title
JPS443476Y1 (cg-RX-API-DMAC10.html)
FR4625M (cg-RX-API-DMAC10.html)
JPS4218277Y1 (cg-RX-API-DMAC10.html)
JPS5256084Y1 (cg-RX-API-DMAC10.html)
JPS4418803Y1 (cg-RX-API-DMAC10.html)
JPS4216201Y1 (cg-RX-API-DMAC10.html)
CS154006B1 (cg-RX-API-DMAC10.html)
BE673712A (cg-RX-API-DMAC10.html)
BE664113A (cg-RX-API-DMAC10.html)
NL6600062A (cg-RX-API-DMAC10.html)
NL6614807A (cg-RX-API-DMAC10.html)
NL6607802A (cg-RX-API-DMAC10.html)
BE666780A (cg-RX-API-DMAC10.html)
BE675053A (cg-RX-API-DMAC10.html)
BE674937A (cg-RX-API-DMAC10.html)
BE661161A (cg-RX-API-DMAC10.html)
NL6613785A (cg-RX-API-DMAC10.html)
NL6503208A (cg-RX-API-DMAC10.html)
SE317619B (cg-RX-API-DMAC10.html)
BE674921A (cg-RX-API-DMAC10.html)
BE675963A (cg-RX-API-DMAC10.html)
BE669168A (cg-RX-API-DMAC10.html)
NL6614723A (cg-RX-API-DMAC10.html)
BE674635A (cg-RX-API-DMAC10.html)
BE674888A (cg-RX-API-DMAC10.html)